BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Q, Hu L, Huang D, Chen K, Qiu X, Qiu B. Six-lncRNA Immune Prognostic Signature for Cervical Cancer. Front Genet 2020;11:533628. [PMID: 33173530 DOI: 10.3389/fgene.2020.533628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhan J, Yang F, Ge C, Yu X. Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer. IJGM 2022;Volume 15:4937-48. [DOI: 10.2147/ijgm.s366925] [Reference Citation Analysis]
2 Fu J, Zhang Y, Wang M, Hu J, Fang Y. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo. J Gene Med 2021;:e3382. [PMID: 34350661 DOI: 10.1002/jgm.3382] [Reference Citation Analysis]
3 Gao Z, Wu D, Zheng W, Zhu T, Sun T, Yuan L, Fei F, Fu P. Prognostic value of immune-related lncRNA pairs in patients with bladder cancer. World J Surg Oncol 2021;19:304. [PMID: 34663340 DOI: 10.1186/s12957-021-02419-8] [Reference Citation Analysis]
4 Mao Y, Chen R, Xia M, Guo P, Zeng F, Huang J, He M. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma. Future Oncol 2021;17:2365-80. [PMID: 33724869 DOI: 10.2217/fon-2020-1153] [Reference Citation Analysis]
5 Gong X, Liu L, Xiong J, Li X, Xu J, Xiao Y, Li J, Luo X, Mao D, Liu L. Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA. J Oncol 2021;2021:6620159. [PMID: 33790966 DOI: 10.1155/2021/6620159] [Reference Citation Analysis]
6 Liu XX, Bao QX, Li YM, Zhang YH. The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway. Bioengineered 2021;12:3322-35. [PMID: 34224325 DOI: 10.1080/21655979.2021.1947174] [Reference Citation Analysis]
7 Liu L, Zhu H, Wang P, Wu S. Construction of a Six-Gene Prognostic Risk Model Related to Hypoxia and Angiogenesis for Cervical Cancer. Front Genet 2022;13:923263. [DOI: 10.3389/fgene.2022.923263] [Reference Citation Analysis]
8 Zhu C, Zhang S, Liu D, Wang Q, Yang N, Zheng Z, Wu Q, Zhou Y. A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer. Front Genet 2021;12:742578. [PMID: 34956313 DOI: 10.3389/fgene.2021.742578] [Reference Citation Analysis]
9 Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers (Basel) 2021;13:5748. [PMID: 34830902 DOI: 10.3390/cancers13225748] [Reference Citation Analysis]
10 Huang Z, Li F, Li Q. Expression profile of RNA binding protein in cervical cancer using bioinformatics approach. Cancer Cell Int 2021;21:647. [PMID: 34863153 DOI: 10.1186/s12935-021-02319-7] [Reference Citation Analysis]
11 Wang Q, Vattai A, Vilsmaier T, Kaltofen T, Steger A, Mayr D, Mahner S, Jeschke U, Hildegard Heidegger H. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients. Int J Mol Sci 2021;22:2442. [PMID: 33671013 DOI: 10.3390/ijms22052442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu X, Wang Z, Wang L, Wang Y, Wang Y, Yang S, Zhang Y. Signature involved in immune-related lncRNA pairs for predicting the immune landscape of cervical cancer. Int J Biol Markers. [DOI: 10.1177/03936155221091832] [Reference Citation Analysis]
13 Sun S, Zhang G, Zhang L. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma. Front Cell Dev Biol 2022;9:790047. [DOI: 10.3389/fcell.2021.790047] [Reference Citation Analysis]
14 Mathias C, Muzzi JCD, Antunes BB, Gradia DF, Castro MAA, Carvalho de Oliveira J. Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes. Front Oncol 2021;11:692170. [PMID: 34136413 DOI: 10.3389/fonc.2021.692170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang D, Wu J, Zhang S, Wu J. Identification of Immune Infiltration-Related ceRNAs as Novel Biomarkers for Prognosis of Patients With Primary Open-Angle Glaucoma. Front Genet 2022;13:838220. [DOI: 10.3389/fgene.2022.838220] [Reference Citation Analysis]